Literature DB >> 17609406

Locoregional recurrence and death from medullary thyroid carcinoma in a contemporaneous series: 5-year results.

Andreas Machens1, Christine Hofmann, Steffen Hauptmann, Henning Dralle.   

Abstract

OBJECTIVE: Studies of outcome in patients with medullary thyroid carcinoma require long follow-ups to accrue enough cancer-specific events. Owing to time-dependent changes in diagnosis and therapy, long observation periods render studies susceptible to 'time bias' which can yield spurious results. This study was designed to investigate cancer-specific event rates after initial neck resection in contemporaneous patients recruited within less than a decade.
DESIGN: Institutional cohort study of 128 consecutive patients who underwent compartment-oriented neck surgery between 1994 and 2002 at a tertiary surgical center for hitherto untreated medullary thyroid carcinoma.
METHODS: The Kaplan-Meier method was used in conjunction with the log-rank test for analysis of time-dependent outcomes.
RESULTS: Follow-up was available for 120 patients (94%) including 63 rearranged during transfection (RET) carriers. There were six locoregional recurrences in the 110 patients with clear surgical margins at initial neck resection, and 12 cancer-specific deaths in the 120 patients with available follow-up. On Kaplan-Meier analysis, most clinicopathological variables were significantly associated with recurrence-free survival and cancer-specific survival. Within the median observation period of 64.5 months, patients with node-negative tumors did not develop locoregional recurrence or die from their malignancies. The low event rates precluded multivariate analyses with all clinicopathological variables. With our extensive surgical approach, median recurrence-free survival and cancer-specific survival at 5 years were 95.2 and 89.3% respectively. DISCUSSION: Compared with literature data, our 5-year locoregional recurrence rate of 4.8% appeared very favorable, and our 5-year cancer-specific mortality rate of 10.7% was among the lowest ever reported. The growing proportion of localized medullary thyroid carcinomas among contemporaneous patients can be expected to ultimately lower the event rates, complicating future studies of outcome.

Entities:  

Mesh:

Year:  2007        PMID: 17609406     DOI: 10.1530/EJE-07-0095

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  12 in total

1.  Alternative surgical strategies in patients with sporadic medullary thyroid carcinoma: Long-term follow-up.

Authors:  Shi Hong Ma; Qin Jiang Liu; You Cheng Zhang; Rong Yang
Journal:  Oncol Lett       Date:  2011-07-05       Impact factor: 2.967

2.  Tumor protein p53-induced nuclear protein (TP53INP1) expression in medullary thyroid carcinoma: a molecular guide to the optimal extent of surgery?

Authors:  D Taïeb; S Giusiano; F Sebag; M Marcy; C de Micco; F F Palazzo; N J Dusetti; J L Iovanna; J F Henry; S Garcia; Colette Taranger-Charpin
Journal:  World J Surg       Date:  2010-04       Impact factor: 3.352

Review 3.  Multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma: an update.

Authors:  Samuel A Wells; Furio Pacini; Bruce G Robinson; Massimo Santoro
Journal:  J Clin Endocrinol Metab       Date:  2013-06-06       Impact factor: 5.958

4.  Role of CDKN2C Copy Number in Sporadic Medullary Thyroid Carcinoma.

Authors:  Elizabeth G Grubbs; Michelle D Williams; Paul Scheet; Selina Vattathil; Nancy D Perrier; Jeffrey E Lee; Robert F Gagel; Tao Hai; Lei Feng; Maria E Cabanillas; Gilbert J Cote
Journal:  Thyroid       Date:  2016-10-18       Impact factor: 6.568

Review 5.  [Cervicovisceral resection in invasive thyroid tumors].

Authors:  M Brauckhoff; H Dralle
Journal:  Chirurg       Date:  2009-02       Impact factor: 0.955

6.  Excellent prognosis of patients with nonhereditary medullary thyroid carcinoma with ultrasonographic findings of follicular tumor or benign nodule.

Authors:  Mitsuhiro Fukushima; Yasuhiro Ito; Mitsuyoshi Hirokawa; Akihiro Miya; Kaoru Kobayashi; Haruki Akasu; Kazuo Shimizu; Akira Miyauchi
Journal:  World J Surg       Date:  2009-05       Impact factor: 3.352

7.  Alternative surgical strategies and favorable outcomes in patients with medullary thyroid carcinoma in Japan: experience of a single institution.

Authors:  Yasuhiro Ito; Akira Miyauchi; Tomonori Yabuta; Mitsuhiro Fukushima; Hiroyuki Inoue; Chisato Tomoda; Takashi Uruno; Minoru Kihara; Takuya Higashiyama; Yuuki Takamura; Akihiro Miya; Kaoru Kobayashi; Fumio Matsuzuka
Journal:  World J Surg       Date:  2009-01       Impact factor: 3.352

8.  (18)F-DOPA PET/CT in the diagnosis and localization of persistent medullary thyroid carcinoma.

Authors:  Aurélien Archier; Céline Heimburger; Carole Guerin; Isabelle Morange; Fausto F Palazzo; Jean-François Henry; Olivier Schneegans; Olivier Mundler; Ahmad Esmaeel Abdullah; Frédéric Sebag; Alessio Imperiale; David Taïeb
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-10-24       Impact factor: 9.236

9.  Association between age and disease specific mortality in medullary thyroid cancer.

Authors:  Zeyad T Sahli; Joseph K Canner; Martha A Zeiger; Aarti Mathur
Journal:  Am J Surg       Date:  2020-09-26       Impact factor: 3.125

10.  Skip metastasis in papillary thyroid carcinoma is difficult to predict in clinical practice.

Authors:  Xilin Nie; Zhou Tan; Minghua Ge
Journal:  BMC Cancer       Date:  2017-10-25       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.